Literature DB >> 23398637

Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.

Johannes Thaler1, Cihan Ay, Nigel Mackman, Sylvia Metz-Schimmerl, Judith Stift, Alexandra Kaider, Leonhard Müllauer, Michael Gnant, Werner Scheithauer, Ingrid Pabinger.   

Abstract

BACKGROUND: Patients with pancreatic cancer have an unfavourable prognosis. A central role in pancreatic cancer progression has been suggested for tissue factor (TF), the main initiator of the blood coagulation cascade. We hypothesized that elevated levels of plasma microparticle (MP)-associated TF activity might indicate the presence of poorly differentiated pancreatic cancer, disease dissemination and infiltration of peripancreatic vessels.
METHODS: MP-TF activity was measured in 73 pancreatic cancer patients and 22 healthy controls. Abdominal computerized tomography (CT) scans performed at study inclusion were investigated for probability of tumoural vascular invasion. In addition, intratumoural TF expression, D-dimer and CA 19-9 levels were determined.
RESULTS: MP-TF activity (pg/mL) was significantly higher in patients (median: 0·37 [range: 0·00-11·91]) than in controls (median: 0·05 [range: 0·00-0·76]; P < 0·001). When pancreatic cancer patients were compared with regard to stage and grade, significantly elevated levels of MP-TF activity were only present in those with poorly differentiated metastatic nonresectable tumours (n = 11, median: 2·95 [range: 0·25-11·91]). In three patients with poorly differentiated tumours, a high probability of vascular invasion was found (MP-TF activity in these cases: 2·95, 7·00 and 10·34). MP-TF activity correlated strongly with CA 19-9 (r = 0·60) and weakly with D-dimer (r = 0·33) levels. Immunohistochemical staining for TF was positive in 14 of 15 resected tumours. MP-TF activity was associated with an increased risk of mortality (HR: 1·8 per doubling in MP-TF activity, [95% CI: 1·4-2·4, P < 0·001]).
CONCLUSION: MP-TF activity might represent a biomarker for a poorly differentiated and invasive pancreatic cancer phenotype and poor survival.
© 2012 The Authors. European Journal of Clinical Investigation © 2012 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23398637     DOI: 10.1111/eci.12042

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  23 in total

Review 1.  Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?

Authors:  Ingrid Pabinger; Julia Riedl
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients.

Authors:  Yohei Hisada; Charlotte Thålin; Staffan Lundström; Håkan Wallén; Nigel Mackman
Journal:  Thromb Res       Date:  2018-03-07       Impact factor: 3.944

Review 3.  Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.

Authors:  Julia E Geddings; Nigel Mackman
Journal:  Blood       Date:  2013-06-24       Impact factor: 22.113

4.  Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

Review 5.  Cancer-associated venous thromboembolism.

Authors:  Alok A Khorana; Nigel Mackman; Anna Falanga; Ingrid Pabinger; Simon Noble; Walter Ageno; Florian Moik; Agnes Y Y Lee
Journal:  Nat Rev Dis Primers       Date:  2022-02-17       Impact factor: 65.038

6.  Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell origin.

Authors:  Gabriela Cesarman-Maus; Esteban Braggio; Carmen Lome-Maldonado; Ana Lilia Morales-Leyte; Rafael Fonseca
Journal:  Thromb Res       Date:  2014-01-23       Impact factor: 3.944

7.  Small but mighty: microparticles as mediators of tumor progression.

Authors:  Tali Voloshin; Ella Fremder; Yuval Shaked
Journal:  Cancer Microenviron       Date:  2014-04-06

8.  Procoagulant extracellular vesicles in amniotic fluid.

Authors:  Lena Hell; Lukas Wisgrill; Cihan Ay; Andreas Spittler; Michael Schwameis; Bernd Jilma; Ingrid Pabinger; Peter Altevogt; Johannes Thaler
Journal:  Transl Res       Date:  2017-02-04       Impact factor: 7.012

Review 9.  Microparticles as Biomarkers of Blood Coagulation in Cancer.

Authors:  Shosaku Nomura; Maiko Niki; Tohru Nisizawa; Takeshi Tamaki; Michiomi Shimizu
Journal:  Biomark Cancer       Date:  2015-10-01

10.  Procoagulant tumor microvesicles attach to endothelial cells on biochips under microfluidic flow.

Authors:  Abdulrahman Algarni; John Greenman; Leigh A Madden
Journal:  Biomicrofluidics       Date:  2019-12-06       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.